Science Explorer Back to mapMap
Discussion
Researcher · Xuzhou Central Hospital · China

Sanyuan Sun

Sanyuan Sun publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Molecular Biology, on topics such as Lung Cancer Treatments and Mutations, Colorectal Cancer Treatments and Studies and Gastric Cancer Management and Outcomes.

ORCID 0000-0002-7477-7491 OpenAlex
World rank
#1,482,601
of 7,710,434 ranked researchers
Rank in China
#220,862
of 978,568
Works
60
Citations
2k
Citations per work
34.0
h-index
22
i10-index 31Top 20% in Oncology
Sanyuan Sun

What does Sanyuan Sun research?

Sanyuan Sun's work is mostly in Medicine (52%), Biochemistry, Genetics and Molecular Biology (24%).

Health Sciences: 31 works · 51.5% of their workMedicine: 31 works · 51.5% of their workOncology: 15 works · 24.9% of their workPulmonary and Respiratory Medicine: 11 works · 19.1% of their workSurgery: 3 works · 4.6% of their workRadiology, Nuclear Medicine and Imaging: 2 works · 2.9% of their workEverything else: 15 works · 24.8% of their workLife Sciences: 14 works · 23.7% of their workBiochemistry, Genetics and Molecular Biology: 14 works · 23.7% of their workMolecular Biology: 10 works · 16.8% of their workCancer Research: 4 works · 6.9% of their workTHEIR WORKSanyuan Sun60works
Life Sciences24%Health Sciences52%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine3151.5%
  2. Everything else1524.8%
    1. Biochemistry, Genetics and Molecular Biology1423.7%
  1. 1Oncology25% of their works
  2. 2Pulmonary and Respiratory Medicine19% of their works
  3. 3Molecular Biology17% of their works
  4. 4Cancer Research7% of their works
  5. 5Surgery5% of their works
  6. 6Radiology, Nuclear Medicine and Imaging3% of their works

Research topics

Which keywords describe Sanyuan Sun's research?

The keywords of their largest research topics: Chemotherapy, Clinical Trials, Targeted Therapy, ALK Inhibitors, EGFR Mutations, Metastatic Breast Cancer, Cetuximab and KRAS Mutations.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 20 words, with their numbers
  1. Chemotherapy223 topics
  2. Clinical Trials182 topics
  3. Targeted Therapy182 topics
  4. ALK Inhibitors121 topic
  5. EGFR Mutations121 topic
  6. Metastatic Breast Cancer112 topics
  7. Cetuximab91 topic
  8. KRAS Mutations91 topic
  9. Endoscopic Resection71 topic
  10. Gastric Cancer71 topic
  11. Cancer61 topic
  12. Chemotherapy-Induced Peripheral Neuropathy61 topic
  13. Genomic Profiles61 topic
  14. Long Noncoding RNAs61 topic
  15. Small-Cell Lung Cancer61 topic
  16. Taxanes61 topic
  17. Breast Cancer51 topic
  18. CDK4/6 Inhibitors51 topic
  19. Immune Checkpoint Blockade51 topic
  20. PD-1 and PD-L151 topic

Where does Sanyuan Sun work?

Sanyuan Sun's main affiliation in the publication record is Xuzhou Central Hospital, China.

How many publications and citations does Sanyuan Sun have?

OpenAlex counts 60 works and 2,037 citations for Sanyuan Sun, an h-index of 22, ranking #1,482,601 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Sanyuan Sun. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.